RU2019144031A3 - - Google Patents

Download PDF

Info

Publication number
RU2019144031A3
RU2019144031A3 RU2019144031A RU2019144031A RU2019144031A3 RU 2019144031 A3 RU2019144031 A3 RU 2019144031A3 RU 2019144031 A RU2019144031 A RU 2019144031A RU 2019144031 A RU2019144031 A RU 2019144031A RU 2019144031 A3 RU2019144031 A3 RU 2019144031A3
Authority
RU
Russia
Application number
RU2019144031A
Other versions
RU2019144031A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019144031A publication Critical patent/RU2019144031A/ru
Publication of RU2019144031A3 publication Critical patent/RU2019144031A3/ru

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
RU2019144031A 2017-05-30 2018-05-29 Способ диагностики или мониторинга функции почек или диагностики дисфункции почек RU2019144031A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17173482.5 2017-05-30
EP17173482 2017-05-30
PCT/EP2018/064049 WO2018219937A1 (en) 2017-05-30 2018-05-29 A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction

Publications (2)

Publication Number Publication Date
RU2019144031A RU2019144031A (ru) 2021-06-30
RU2019144031A3 true RU2019144031A3 (ru) 2021-09-22

Family

ID=59021256

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019144031A RU2019144031A (ru) 2017-05-30 2018-05-29 Способ диагностики или мониторинга функции почек или диагностики дисфункции почек

Country Status (10)

Country Link
US (1) US20200182885A1 (ru)
EP (1) EP3631459A1 (ru)
JP (1) JP7271442B2 (ru)
CN (1) CN110678757B (ru)
AU (1) AU2018276361A1 (ru)
BR (1) BR112019024966A2 (ru)
CA (1) CA3065415A1 (ru)
MX (1) MX2019014441A (ru)
RU (1) RU2019144031A (ru)
WO (1) WO2018219937A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110060337B (zh) * 2019-04-25 2021-03-02 飞依诺科技(苏州)有限公司 颈动脉超声扫查三维重建方法及系统
WO2022263648A1 (en) * 2021-06-18 2022-12-22 Sphingotec Gmbh A method for predicting sepsis and septic shock

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634716B2 (en) 1988-08-01 1993-03-04 Ciba Corning Diagnostics Corp. Method for detection of an analyte using acridinium esters and liposomes
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
JP2005508623A (ja) 2001-08-30 2005-04-07 バイオレクシス ファーマシューティカル コーポレイション 改変されたトランスフェリン融合タンパク質
ES2559927T3 (es) 2002-06-07 2016-02-16 Dyax Corp. Prevención y reducción de pérdida de sangre y respuesta inflamatoria
EP1675878A2 (en) 2003-10-24 2006-07-05 Avidia, Inc. Ldl receptor class a and egf domain monomers and multimers
US20100028995A1 (en) 2004-02-23 2010-02-04 Anaphore, Inc. Tetranectin Trimerizing Polypeptides
EP1793847A2 (en) 2004-09-21 2007-06-13 NascaCell IP GmbH Use of microproteins as tryptase inhibitors
WO2008060607A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
WO2009077175A1 (en) 2007-12-19 2009-06-25 Affibody Ab Polypeptide derived from protein a and able to bind pdgf
ES2836948T3 (es) 2008-11-03 2021-06-28 Molecular Partners Ag Proteínas de unión que inhiben la interacción del receptor de VEGF-A
US8460884B2 (en) * 2008-11-05 2013-06-11 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Use of hematopoietic growth factor inducible neurokinin-1 (HGFIN) as a biomarker for renal injury or renal disease
CN106546752A (zh) * 2009-02-06 2017-03-29 阿斯图特医药公司 肾损伤和肾衰竭的诊断及预后
EP2427764B1 (en) * 2009-05-05 2017-07-26 B.R.A.H.M.S GmbH Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
NZ598351A (en) 2009-08-27 2014-08-29 Covagen Ag Il-17 binding compounds and medical uses thereof
CN102753569A (zh) 2009-12-14 2012-10-24 塞尔蛋白质股份有限公司 对纤维连接蛋白额外结构域b具有特异结合活性的修饰的泛素蛋白
CN105949301B (zh) 2010-06-08 2020-03-27 皮里斯制药有限公司 结合IL-4受体α的泪脂质运载蛋白突变蛋白
US8501418B2 (en) * 2010-08-06 2013-08-06 Pronata N.V. Method of treating renal dysfunction based on perlecan as a biomarker
ES2674822T3 (es) 2012-10-02 2018-07-04 Sphingotec Gmbh Método para diagnosticar o monitorizar la función renal o diagnosticar la disfunción renal
CA2897245A1 (en) * 2013-01-08 2014-07-17 Sphingotec Gmbh A method for predicting the risk of getting cancer or diagnosing cancer in a subject
ES2731531T3 (es) * 2013-10-01 2019-11-15 Sphingotec Gmbh Método para predecir el riesgo de experimentar un episodio cardiaco adverso grave
WO2015070041A1 (en) * 2013-11-08 2015-05-14 Icahn School Of Medicine At Mount Sinai Methods for monitoring kidney dysfunction
US20160279186A1 (en) 2014-03-25 2016-09-29 Desmond D. Mascarenhas Modulation of epigenetic stress response

Also Published As

Publication number Publication date
CN110678757A (zh) 2020-01-10
CA3065415A1 (en) 2018-12-06
US20200182885A1 (en) 2020-06-11
JP2020521973A (ja) 2020-07-27
RU2019144031A (ru) 2021-06-30
AU2018276361A1 (en) 2019-12-05
CN110678757B (zh) 2024-04-05
WO2018219937A1 (en) 2018-12-06
MX2019014441A (es) 2020-02-10
JP7271442B2 (ja) 2023-05-11
EP3631459A1 (en) 2020-04-08
BR112019024966A2 (pt) 2020-06-23

Similar Documents

Publication Publication Date Title
BR122022003522A2 (ru)
BR112019008823A2 (ru)
BR112020006084A8 (ru)
BR202018014992U2 (ru)
BR112020008820A2 (ru)
BR202017025154U2 (ru)
BR102017023327A2 (ru)
BR202017021228U2 (ru)
BR202017020981U2 (ru)
BR202017017068U2 (ru)
BR202017016984U2 (ru)
BR202017016924U2 (ru)
BR102017015495A2 (ru)
BR102017015250A2 (ru)
BR102017014430A2 (ru)
BR202017012548U2 (ru)
BR202017010814U2 (ru)
BR102017003115A2 (ru)
CN303996561S (ru)
CN303991388S (ru)
CN304028516S (ru)
CN304025735S (ru)
CN304014058S (ru)
CN304004601S (ru)
CN304031415S (ru)